107 related articles for article (PubMed ID: 6315025)
1. Activation of platelets and of fibrinolysis by venous occlusion in healthy volunteers and influence of suloctidil in comparison with placebo.
Baele G; Bary JL; van Stalle F
Arzneimittelforschung; 1983; 33(8):1203-5. PubMed ID: 6315025
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.).
Moriau M; Col-De Beys C; Pardonge E; Ferrant A
Thromb Haemost; 1982 Feb; 47(1):27-31. PubMed ID: 6280332
[TBL] [Abstract][Full Text] [Related]
3. Effects of suloctidil on platelet survival time following cardiac valve replacement.
Col-de Beys C; Ferrant A; Moriau M
Thromb Haemost; 1981 Aug; 46(2):550-3. PubMed ID: 6272442
[TBL] [Abstract][Full Text] [Related]
4. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
Legnani C; Frascaro M; Guazzaloca G; Ludovici S; Cesarano G; Coccheri S
Arzneimittelforschung; 1993 Feb; 43(2):119-22. PubMed ID: 8457236
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
[TBL] [Abstract][Full Text] [Related]
6. In vivo effect of suloctidil as an antiplatelet agent.
Stelzer MR; Burns TS; Saunders RN
Thromb Haemost; 1979 May; 41(3):465-74. PubMed ID: 462414
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
[TBL] [Abstract][Full Text] [Related]
8. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
Baro F; Malfroid M; Waegemans T; Cox JP
Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
[TBL] [Abstract][Full Text] [Related]
9. Effect of suloctidil on platelet function in patients with shortened platelet survival time.
Turpie AG; Gent M; deBoer AC; Giroux M; Kinch D; Butt R; Gunstensen J; Saerens E; Genton E
Thromb Res; 1984 Aug; 35(4):397-406. PubMed ID: 6091290
[TBL] [Abstract][Full Text] [Related]
10. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
Merchan R; Zurita IE; Martinez JF
Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
[TBL] [Abstract][Full Text] [Related]
11. The influence of beta-adrenergic blockade upon baseline blood coagulation and fibrinolytic activity and upon the responses to venous occlusion.
Butler MJ; Smith M; Irving MH; Gordon YB; Ratky SM; Rivers JW; Hawkey C
Thromb Diath Haemorrh; 1975 Sep; 34(1):169-80. PubMed ID: 1188710
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic response to interferon-alpha in healthy human subjects.
Corssmit EP; Levi M; Hack CE; ten Cate JW; Sauerwein HP; Romijn JA
Thromb Haemost; 1996 Jan; 75(1):113-7. PubMed ID: 8713789
[TBL] [Abstract][Full Text] [Related]
13. Magnesium inhibits platelet activity--an infusion study in healthy volunteers.
Ravn HB; Vissinger H; Kristensen SD; Wennmalm A; Thygesen K; Husted SE
Thromb Haemost; 1996 Jun; 75(6):939-44. PubMed ID: 8822590
[TBL] [Abstract][Full Text] [Related]
14. [Effect of suloctidil on the reduced evoked potentials in brain slices in low glucose perfusate].
Nishi H; Hori N; Katsuda N
Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):321-33. PubMed ID: 6323287
[TBL] [Abstract][Full Text] [Related]
15. [The effect of suloctidil and acetylsalicylic acid on eicosanoid synthesis in human platelets].
Tkaczewski W; Buczyński A; Dziedziczak-Buczyńska M; Wachowicz B; Kedziora J
Pol Tyg Lek; 1992 Oct 19-26; 47(42-43):970-1. PubMed ID: 1338656
[TBL] [Abstract][Full Text] [Related]
16. Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers.
Albert J; Wall n NH; Li N; Frostell C; Hjemdahl P
Clin Sci (Lond); 1999 Sep; 97(3):345-53. PubMed ID: 10464060
[TBL] [Abstract][Full Text] [Related]
17. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
[TBL] [Abstract][Full Text] [Related]
18. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
19. Effect of suloctidil on tomographically quantitated platelet accumulation in Dacron aortic grafts.
Stratton JR; Ritchie JL
Am J Cardiol; 1986 Jul; 58(1):152-6. PubMed ID: 3014851
[TBL] [Abstract][Full Text] [Related]
20. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]